NCT04934462 Evaluation of Non-Surgical and Arthroscopic Treatment for Hip Microinstability
| NCT ID | NCT04934462 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Göteborg University |
| Condition | Musculoskeletal Abnormalities |
| Study Type | INTERVENTIONAL |
| Enrollment | 26 participants |
| Start Date | 2021-11-26 |
| Primary Completion | 2026-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 26 participants in total. It began in 2021-11-26 with a primary completion date of 2026-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Microinstability of the hip joint is an important cause of hip pain and reduced hip function in young and active individuals. Hip microinstability is due to extraphysiologic hip motion and could be secondary to acetabular dysplasia, connective tissue disorder, macrotrauma, microtrauma, iatrogenic- and idiopathic causes. Treatment for hip microinstability is initiated with non-surgical treatment consisting of physiotherapy aimed mainly at stability. If non-surgical treatment fails, surgery with arthroscopic plication of the hip joint capsule is the preferred method. This study evaluates non-surgical and arthroscopic treatment for hip microinstability regarding hip function and adverse events.
Eligibility Criteria
Inclusion Criteria: * Hip microinstability * Minimum 18 years old Exclusion Criteria: * Hip osteoarthritis * Severe hip dysplasia * Perthes disease or avascular necrosis of the femoral head * Previous surgery to the hip joint
Contact & Investigator
Mikael Sansone, MD, PhD
STUDY DIRECTOR
Göteborg University
Frequently Asked Questions
Who can join the NCT04934462 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Musculoskeletal Abnormalities. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04934462 currently recruiting?
Yes, NCT04934462 is actively recruiting participants. Contact the research team at axel.ohlin@gmail.com for enrollment information.
Where is the NCT04934462 trial being conducted?
This trial is being conducted at Gothenburg, Sweden, Gothenburg, Sweden, Stockholm, Sweden.
Who is sponsoring the NCT04934462 clinical trial?
NCT04934462 is sponsored by Göteborg University. The principal investigator is Mikael Sansone, MD, PhD at Göteborg University. The trial plans to enroll 26 participants.